1. TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection
   Jin-Wu Hu et al, 2020, Digestive and Liver Disease CrossRef
2. Circ_0007624 suppresses the development of esophageal squamous cell carcinoma via targeting miR-224-5p/CPEB3 to inactivate the EGFR/PI3K/AKT signaling
   Jiwei Cheng et al, 2022, Cellular Signalling CrossRef
3. Transglutaminase 3 suppresses proliferation and cisplatin resistance of cervical cancer cells by inactivation of the PI3K/AKT pathway
   Ruipu Chen et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
4. Novel FMRP interaction networks linked to cellular stress
   Mohamed S. Taha et al, 2021, The FEBS Journal CrossRef
5. Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
   Seema Nayak et al, 2018, PLOS ONE CrossRef
6. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer
   Xiangbing Wu et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
7. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker
   Wenqing Zhang et al, 2023, Frontiers in Genetics CrossRef
8. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation
   Kaili Zhou et al, 2024, Cell Death & Disease CrossRef
9. Significantly mutated genes and regulatory pathways in SCLC—a meta-analysis
   Varsha Sundaresan et al, 2017, Cancer Genetics CrossRef
10. Comment on “TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)”
    Muthupandian Saravanan, 2024, Oral Oncology Reports CrossRef
11. Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
    Richard L. Eckert, 2019, Molecular Carcinogenesis CrossRef
12. Saliva-omics in plasma cell disorders- Proof of concept and potential as a non-invasive tool for monitoring disease burden
    Ciara Tierney et al, 2021, Journal of Proteomics CrossRef
13. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile
    Deng Wu et al, 2022, Clinics and Research in Hepatology and Gastroenterology CrossRef
14. Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
    Elina S. Chermnykh et al, 2020, Cells CrossRef
15. Identification of crucial long non-coding RNAs and mRNAs along with related regulatory networks through microarray analysis in esophageal carcinoma
    Yaowen Zhang et al, 2021, Functional & Integrative Genomics CrossRef
16. SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p
    Shihui Zhang et al, 2022, Cancer Biology & Therapy CrossRef